Prostate cancer is a common but complex disease with a number of unresolved issues surrounding its natural history. These include concerns with screening, detection, and treatment, and reflect the substantial heterogeneity in prostate tumors: some will remain latent and have little impact on morbidity, whereas others progress rapidly in a potentially lethal manner. Genetic factors likely underlie some of these differences, and we propose a comprehensive evaluation of the genetic basis of prostate cancer risk and progression in a large, well-characterized study population. In particular, we will investigate rar functional variants across the exome and common SNPs across the genome. Our sample encompasses 8,078 prostate cancer cases and 8,078 age and ethnicity matched controls nested within the Kaiser / USCF Research Program on Genes, Environment and Health cohort. This population has existing genome-wide SNP measures, and uniformly collected clinical information on prostate cancer screening, diagnoses, and progression. We plan to type the new exome array on the cases and controls to assess the functional variants in protein coding regions across the human genome. With these data we will address our hypothesis that these genetic factors can be used to predict-and underlie an increasing proportion of the variation in-prostate cancer risk and progression. This project provides an efficient and innovative opportunity to obtain a comprehensive understanding of how these factors impact the natural history of prostate cancer. Our findings should supply important insights into the underlying mechanism of disease, with the ultimate goal of helping to improve screening and treatment for prostate cancer.
Prostate cancer is one of the most common and clearly genetic cancers, but finding the mechanisms underlying the natural history of this disease has proven difficult. Our efforts toward deciphering the genetic basis of prostate cancer will help improve screening, treatment, and our understanding of this disease, all important goals of the overall National Cancer Institute's Mission. These advances will improve the overall health of men, providing much needed information about individual and population-level risks of prostate cancer development and progression.
|Majumdar, Arunabha; Haldar, Tanushree; Witte, John S (2016) Determining Which Phenotypes Underlie a Pleiotropic Signal. Genet Epidemiol 40:366-81|
|Lindquist, Karla J; Paris, Pamela L; Hoffmann, Thomas J et al. (2016) Mutational Landscape of Aggressive Prostate Tumors in African American Men. Cancer Res 76:1860-8|
|Scarbrough, Peter M; Weber, Rachel Palmieri; Iversen, Edwin S et al. (2016) A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer. Cancer Epidemiol Biomarkers Prev 25:193-200|
|Uricchio, Lawrence H; Zaitlen, Noah A; Ye, Chun Jimmie et al. (2016) Selection and explosive growth alter genetic architecture and hamper the detection of causal rare variants. Genome Res 26:863-73|
|Rand, Kristin A; Rohland, Nadin; Tandon, Arti et al. (2016) Whole-exome sequencing of over 4100 men of African ancestry and prostate cancer risk. Hum Mol Genet 25:371-81|
|Han, Ying; Rand, Kristin A; Hazelett, Dennis J et al. (2016) Prostate Cancer Susceptibility in Men of African Ancestry at 8q24. J Natl Cancer Inst 108:|
|Han, Ying; Signorello, Lisa B; Strom, Sara S et al. (2015) Generalizability of established prostate cancer risk variants in men of African ancestry. Int J Cancer 136:1210-7|
|Han, Ying; Hazelett, Dennis J; Wiklund, Fredrik et al. (2015) Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions. Hum Mol Genet 24:5603-18|
|Tai, Caroline G; Graff, Rebecca E; Liu, Jinghua et al. (2015) Detecting gene-environment interactions in human birth defects: Study designs and statistical methods. Birth Defects Res A Clin Mol Teratol 103:692-702|
|Uricchio, Lawrence H; Torres, Raul; Witte, John S et al. (2015) Population genetic simulations of complex phenotypes with implications for rare variant association tests. Genet Epidemiol 39:35-44|
Showing the most recent 10 out of 84 publications